| Intuniv (guanfacine XR) / Shionogi, Takeda |
NCT01069523: Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 42 | US | Guanfacine Extended Release, Intuniv, Placebo | The University of Texas Health Science Center at San Antonio, Shire | Attention Deficit Disorder With Hyperactivity | 08/11 | 08/11 | | |
NCT01156051: Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia |
|
|
| Terminated | 4 | 29 | US | Guanfacine extended-release tablets, Intuniv (TM), guanfacine HCl, SPD503, Placebo comparator, "sugar pill" | Children's Specialized Hospital, Shire | Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder, Insomnia, Sleep Disorders | 02/12 | 02/12 | | |
NCT01709695: Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD |
|
|
| Completed | 4 | 27 | US | Guanfacine Hydrochloride XR, INTUNIV non-stimulant medication, GXR, Placebo | Icahn School of Medicine at Mount Sinai | ADHD, Attention Deficit Hyperactivity Disorder | 12/13 | 12/13 | | |
NCT01985581: Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD |
|
|
| Completed | 4 | 50 | Canada | Guanfacine extended release, Intuniv extended release, Placebo, Stimulant therapy | JPM van Stralen Medicine Professional | Attention Deficit Hyperactivity Disorder | 03/15 | 03/15 | | |
